Hepatic and gastric cytoprotective effects of long-term prostaglandin E1 administration in cirrhotic rats

This publication has 23 references indexed in Scilit:

• Modulation of thioacetamide‐induced hepatocellular necrosis by prostaglandins is associated with novel histologic changes
  Liver International, 1992
• Effects of Prostaglandin E₁on the Recovery of Ischemia-Induced Liver Mitochondrial Dysfunction in Rats with Cirrhosis
  Scandinavian Journal of Gastroenterology, 1991
• Gastric mucosal prostaglandin E2 levels in cirrhosis and portal hypertension
  Journal of Hepatology, 1990
• The gastric mucosa in portal hypertension
  Journal of Hepatology, 1989
• Estimation of collagen content of liver specimens. Variation among animals and among hepatic lobes in cirrhotic rats.
  Journal of Histochemistry & Cytochemistry, 1989
• 16, 16 Dimethyl prostaglandin E2 prevents the development of fulminant hepatitis and blocks the induction of monocyte/macrophage procoagulant activity after murine hepatitis virus strain 3 infection.
  Journal of Clinical Investigation, 1987
• Relationship between degree of portal hypertension and liver histologic lesions in patients with alcoholic cirrhosis
  Digestive Diseases and Sciences, 1987
• Cytoprotective effect of prostaglandins on isolated rat liver cells
  Liver International, 1985
• 16,16-Dimethyl-PGE2 Protection Against α — Napthy lisothiocy anate - Induced Experimental Cholangitis in the Rat
  Hepatology, 1984
• Reduction by cytoprotective agents of ethanol-induced damage to the rat gastric mucosa: a correlated morphological and physiological study
  Canadian Journal of Physiology and Pharmacology, 1982